Immunization with the recombinant antigen Ss-IR induces protective immunity to infection with Strongyloides stercoralis in mice

Vaccine

Volumn 29, Issue 45, 2011, Pages 8134-8140

  Abraham, David ^a   Hess, Jessica A ^a   Mejia, Rojelio ^b   Nolan, Thomas J ^c   Lok, James B ^c   Lustigman, Sara ^d   Nutman, Thomas B ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d NEW YORK BLOOD CENTER   (United States)

Author keywords

Recombinant vaccine; Ss IR; Strongyloides stercoralis

Indexed keywords

IMMUNOGLOBULIN G; RECOMBINANT ANTIGEN; RECOMBINANT ANTIGEN SS EAT 6; RECOMBINANT ANTIGEN SS IR; RECOMBINANT ANTIGEN SS LEC 5; RECOMBINANT ANTIGEN SS NIE 1; RECOMBINANT ANTIGEN SS TMY 1; RECOMBINANT VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; BLOOD ANALYSIS; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; LARVA; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTECTION; STRONGYLOIDES STERCORALIS;

ADJUVANTS, IMMUNOLOGIC; ALUM COMPOUNDS; ANIMAL STRUCTURES; ANIMALS; ANTIBODIES, HELMINTH; ANTIGENS, HELMINTH; LARVA; MALE; MICE; MICE, INBRED BALB C; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; SURVIVAL ANALYSIS;

EID: 80053633600     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.08.030     Document Type: Article

References (35)

1. Croker C., Reporter R., Redelings M., Mascola L. Strongyloidiasis-related deaths in the United States, 1991-2006. Am J Trop Med Hyg 2010, 83:422-426.
2. Keiser P.B., Nutman T.B. Strongyloides stercoralis in the immunocompromised population. Clin Microbiol Rev 2004, 17:208-217.
3. Ramanathan R., Nutman T. Strongyloides stercoralis infection in the immunocompromised host. Curr Infect Dis Rep 2008, 10:105-110.
4. Montes M., Sanchez C., Verdonck K., Lake J.E., Gonzalez E., Lopez G., et al. T cell expansion in HTLV-1 and strongyloidiasis co-infection is associated with reduced IL-5 responses to Strongyloides stercoralis antigen. PLoS Negl Trop Dis 2009, 3:e456.
5. Horton J. Albendazole: a review of anthelmintic efficacy and safety in humans. Parasitology 2000, 121(Suppl.):S113-S132.
6. Ikeda T. Pharmacological effects of ivermectin, an antiparasitic agent for intestinal strongyloidiasis: its mode of action and clinical efficacy. Nippon Yakurigaku Zasshi 2003, 122:527-538.
7. Geary T.G., Woo K., McCarthy J.S., Mackenzie C.D., Horton J., Prichard R.K., et al. Unresolved issues in anthelmintic pharmacology for helminthiases of humans. Int J Parasitol 2010, 40:1-13.
8. Osei-Atweneboana M.Y., Awadzi K., Attah S.K., Boakye D.A., Gyapong J.O., Prichard R.K. Phenotypic evidence of emerging ivermectin resistance in Onchocerca volvulus. PLoS Negl Trop Dis 2011, 5:e998.
9. Bergquist R., Lustigman S. Control of important helminthic infections vaccine development as part of the solution. Adv Parasitol 2010, 73:297-326.
10. Samykutty A., Dakshinamoorthy G., Kalyanasundaram R. Multivalent vaccine for lymphatic filariasis. Procedia Vaccinol 2010, 3:12-18.
11. Bethony J., Loukas A., Smout M., Brooker S., Mendez S., Plieskatt J., et al. Antibodies against a secreted protein from hookworm larvae reduce the intensity of hookworm infection in humans and vaccinated laboratory animals. FASEB J 2005, 19:1743-1745.
12. Bethony J.M., Simon G., Diemert D.J., Parenti D., Desrosiers A., Schuck S., et al. Randomized, placebo-controlled, double-blind trial of the Na-ASP-2 hookworm vaccine in unexposed adults. Vaccine 2008, 26:2408-2417.
13. Ghosh K., Hawdon J., Hotez P. Vaccination with alum-precipitated recombinant Ancylostoma-secreted protein 1 protects mice against challenge infections with infective hookworm (Ancylostoma caninum) larvae. J Infect Dis 1996, 174:1380-1383.
14. Goud G.N., Zhan B., Ghosh K., Loukas A., Hawdon J., Dobardzic A., et al. Cloning, yeast expression, isolation, and vaccine testing of recombinant Ancylostoma-secreted protein (ASP)-1 and ASP-2 from Ancylostoma ceylanicum. J Infect Dis 2004, 189:919-929.
15. Mendez S., Zhan B., Goud G., Ghosh K., Dobardzic A., Wu W., et al. Effect of combining the larval antigens Ancylostoma secreted protein 2 (ASP-2) and metalloprotease 1 (MTP-1) in protecting hamsters against hookworm infection and disease caused by Ancylostoma ceylanicum. Vaccine 2005, 23:3123-3130.
16. Zhan B., Perally S., Brophy P.M., Xue J., Goud G., Liu S., et al. Molecular cloning, biochemical characterization, and partial protective immunity of the heme-binding glutathione S-transferases from the human hookworm Necator americanus. Infect Immun 2010, 78:1552-1563.
17. Iriemenam N.C., Sanyaolu A.O., Oyibo W.A., Fagbenro-Beyioku A.F. Strongyloides stercoralis and the immune response. Parasitol Int 2010, 59:9-14.
18. Abraham D., Rotman H.L., Haberstroh H.F., Yutanawiboonchai W., Brigandi R.A., Leon O., et al. Strongyloides stercoralis: protective immunity to third-stage larvae in BALB/cByJ mice. Exp Parasitol 1995, 80:297-307.
19. Brigandi R.A., Rotman H.L., Yutanawiboonchai W., Leon O., Nolan T.J., Schad G.A., et al. Strongyloides stercoralis: role of antibody and complement in immunity to the third stage of larvae in BALB/cByJ mice. Exp Parasitol 1996, 82:279-289.
20. Kerepesi L.A., Nolan T.J., Schad G.A., Lustigman S., Herbert D.R., Keiser P.B., et al. Human immunoglobulin G mediates protective immunity and identifies protective antigens against larval Strongyloides stercoralis in mice. J Infect Dis 2004, 189:1282-1290.
21. Ligas J.A., Kerepesi L.A., Galioto A.M., Lustigman S., Nolan T.J., Schad G.A., et al. Specificity and mechanism of immunoglobulin M (IgM)- and IgG-dependent protective immunity to larval Strongyloides stercoralis in mice. Infect Immun 2003, 71:6835-6843.
22. Herbert D.R., Nolan T.J., Schad G.A., Lustigman S., Abraham D. Immunoaffinity-isolated antigens induce protective immunity against larval Strongyloides stercoralis in mice. Exp Parasitol 2002, 100:112-120.
23. + ATPase (Sseat-6) induces protective immunity to larval Strongyloides stercoralis in mice. Infect Immun 2005, 73:2298-2305.
24. Lambrecht B.N., Kool M., Willart M.A., Hammad H. Mechanism of action of clinically approved adjuvants. Curr Opin Immunol 2009, 21:23-29.
25. Lindblad E.B. Aluminium compounds for use in vaccines. Immunol Cell Biol 2004, 82:497-505.
26. Rotman H.L., Schnyder-Candrian S., Scott P., Nolan T.J., Schad G.A., Abraham D. IL-12 eliminates the Th-2 dependent protective immune response of mice to larval Strongyloides stercoralis. Parasite Immunol 1997, 19:29-39.
27. Ramanathan R., Burbelo P.D., Groot S., Iadarola M.J., Neva F.A., Nutman T.B. A luciferase immunoprecipitation systems assay enhances the sensitivity and specificity of diagnosis of Strongyloides stercoralis infection. J Infect Dis 2008, 198:444-451.
28. Irvine M., Huima T., Prince A.M., Lustigman S. Identification and characterization of an Onchocerca volvulus cDNA clone encoding a highly immunogenic calponin-like protein. Mol Biochem Parasitol 1994, 65:135-146.
29. Moore T.A., Ramachandran S., Gam A.A., Neva F.A., Lu W., Saunders L., et al. Identification of novel sequences and codon usage in Strongyloides stercoralis. Mol Biochem Parasitol 1996, 79:243-248.
30. Ravi V., King T.P., Andersen J.F., Nutman T.B., Neva F.A. Strongyloides stercoralis recombinant NIE antigen shares epitope with recombinant Ves v 5 and Pol a 5 allergens of insects. Am J Trop Med Hyg 2005, 72:549-553.
31. Krolewiecki A.J., Ramanathan R., Fink V., McAuliffe I., Cajal S.P., Won K., et al. Improved diagnosis of Strongyloides stercoralis using recombinant antigen-based serologies in a community-wide study in northern Argentina. Clin Vaccine Immunol 2010, 17:1624-1630.
32. Vlaminck J., Lopez-Aban J., Ruano A.L., del Olmo E., Muro A. Vaccination against Strongyloides venezuelensis with homologue antigens using new immunomodulators. J Parasitol 2010, 96:643-647.
33. Marcilla A., Sotillo J., Perez-Garcia A., Igual-Adell R., Valero M.L., Sanchez-Pino M.M., et al. Proteomic analysis of Strongyloides stercoralis L3 larvae. Parasitology 2010, 137:1577-1583.
34. Galioto A.M., Hess J.A., Nolan T.J., Schad G.A., Lee J.J., Abraham D. Role of eosinophils and neutrophils in innate and adaptive protective immunity to larval Strongyloides stercoralis in mice. Infect Immun 2006, 74:5730-5738.
35. Kerepesi L.A., Hess J.A., Nolan T.J., Schad G.A., Abraham D. Complement component C3 is required for protective innate and adaptive immunity to larval Strongyloides stercoralis in mice. J Immunol 2006, 176:4315-4322.